“71 Table of Contents The $167.0 million increase in cash used in investing activities for the six months ended June 30, 2026 compared to the same period in 2025 was primarily used for acquisitions, partially offset by maturities of our investments and reduced…”10-Q · Jul 27, 2026 ↗
The Ensign Group, Inc.
ENSG
Market read
The Ensign Group, Inc.'s move is spreading beyond its market group.
ENSG accounts for 15.1% of the group's measured movement across 5.8 effective names. raw member direction is mixed; 7 of 12 session-normalized paths align to the downside. Capital-flow agreement is 13%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
CASY moved materially before ENSG. ENSG crossed its material path threshold at 15:55 ET. AHR, AB, ADC followed.
- Revenue increased 18.4% versus the comparable filing period.
5 of 19 members in Healthcare REITs are active. 0 of 3 disclosed connections are confirming.
- At least 13 of 19 durable members become active together.
- Capital-flow agreement rises above 55%.
- VTR remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 6 of 19 members or fewer.
Research brief
The story so far
ENSG accounts for 15.1% of the group's measured movement across 5.8 effective names. raw member direction is mixed; 7 of 12 session-normalized paths align to the downside. Capital-flow agreement is 13%, so confirmation is not yet clean. No verified headline preceded the measured group move.
- Revenue increased 18.4% versus the comparable filing period.
- Net income increased 24.2% versus the comparable filing period.
- Operating cash flow covered net income at 1.00x, improving versus the comparable period.
No thresholded adverse filing evidence is available yet.
- At least 13 of 19 durable members become active together.
- Capital-flow agreement rises above 55%.
- VTR remains aligned with the group in the next market snapshot.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +18.8% year over year.
- Operating cash flow covered net income at 1.64x in the latest annual period.
No qualifying adverse evidence was identified; that is not proof there is no downside.
No credible peer-relative valuation comparison is available yet.
Price as of Sep 11, 2026
174.14Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“58 Table of Contents We calculate EBITDA as net income, adjusted for net losses attributable to noncontrolling interest, before (a) interest income, (b) provision for income taxes, (c) depreciation and amortization, and (d) interest expense.”10-Q · Jul 27, 2026 ↗
“Some of our independent subsidiaries have been or will be in denial of payment status due to findings of continued regulatory deficiencies, resulting in an actual loss of revenue associated with patients admitted after the denial of payment date.”10-Q · Apr 30, 2026 ↗
“Increased Demand Driven by Aging Populations — As seniors account for an increasing percentage of the total U.S.”10-K · Feb 4, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 2.0× · EV/sales 2.0×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for ENSG. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Latest filing assessment · baseline
Fundamentals strengthened in the latest filing
10-Q filed 2026-04-30 against the comparable filing from 2025-04-29.
What improved
- Revenue increased 18.4% versus the comparable filing period.
- Net income increased 24.2% versus the comparable filing period.
- Operating cash flow covered net income at 1.00x, improving versus the comparable period.
What weakened
No thresholded deterioration was identified.
Filing receipts
“Cost of services as a percentage of revenue decreased by 0.3% to 79.1% reflecting continued cost management, a shift towards higher acuity as we serve more clinically complex patients, and improving operational performance at our newer acquisitions.”
“This increase was primarily related to the additional depreciation incurred as a result of our newly acquired operations, which have a greater mix of real estate purchases than leases, and capital investments.”
“Other income, net decreased by $1.5 million due primarily due to a $1.7 million loss on our deferred compensation plan and a decrease in interest income of $0.3 million as we utilized our cash on hand to fund more real estate purchases during the period coupled with a lower interest rate environment.”
Retrospective baseline calibration. It was generated after the filing date and is not part of Jodie's live track record.
Business ecosystem
The relationships behind ENSG
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CTRECareTrust REIT, Inc.partnerApr 30, 2026 ▾
“Operating Leases As of March 31, 2026, 254 of our facilities have long-term lease arrangements, of which 104 of the operations are under eight triple-net Master Leases with CareTrust.”
CTRECareTrust REIT, Inc.investeeJul 24, 2025 ▾
“During the six months ended June 30, 2025, we, through Standard Bearer, exercised the option to purchase the real estate of four facilities from CareTrust for $44.6 million.”
TFCTruist Financial CorporationlenderApr 30, 2026 ▾
“59 Table of Contents Credit Facility with a Lending Consortium Arranged by Truist We maintain a revolving credit facility with Truist Securities (Truist) (the Credit Facility) with availability of up to $600.0 million in aggregate principal.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ENSG is currently a Early Follower in the organic co-movement group Healthcare REITs. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.